Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.285
+0.095 (2.98%)
Oct 21, 2026, 4:00 PM EDT - Market closed
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 32 employees as of June 30, 2026. The number of employees increased by 11 or 52.38% compared to the same quarter last year. That makes Whitehawk Therapeutics the 36,936th largest employer in the world and 5,123rd in the United States.
Employees
32
Change (1Y)
11
Growth (1Y)
52.38%
Revenue / Employee
n/a
Profits / Employee
-$2,494,719
Market Cap
187.27M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 32 | 11 | 52.38% |
| Mar 31, 2026 | 29 | 11 | 61.11% |
| Dec 31, 2025 | 23 | -17 | -42.50% |
| Sep 30, 2025 | 22 | -31 | -58.49% |
| Jun 30, 2025 | 21 | -49 | -70.00% |
| Mar 31, 2025 | 18 | -57 | -76.00% |
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Sep 30, 2024 | 53 | -35 | -39.77% |
| Jun 30, 2024 | 70 | -19 | -21.35% |
| Mar 31, 2024 | 75 | -5 | -6.25% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Sep 30, 2023 | 88 | 12 | 15.79% |
| Jun 30, 2023 | 89 | 22 | 32.84% |
| Mar 31, 2023 | 80 | 26 | 48.15% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Sep 30, 2022 | 76 | 55 | 261.90% |
| Jun 30, 2022 | 67 | 57 | 570.00% |
| Mar 31, 2022 | 54 | 44 | 440.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Entrada Therapeutics | 152 |
| Sutro Biopharma | 128 |
| Invivyd | 122 |
| Cartesian Therapeutics | 75 |
| Alpha Cognition | 71 |
| Precision BioSciences | 67 |
| Sionna Therapeutics | 59 |
| ALX Oncology Holdings | 48 |
WHWK News
- 20 days ago - Whitehawk Therapeutics presents real-world analyses of MUC16 in ovarian cancer - TheFly
- 20 days ago - Whitehawk Therapeutics Presents Real-World Analyses Supporting MUC16 as a Durable ADC Target in Ovarian Cancer at IGCS 2026 - PRNewsWire
- 21 days ago - Whitehawk Therapeutics initiated with a Buy at Stifel - TheFly
- 5 weeks ago - Whitehawk Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 5 weeks ago - Whitehawk Therapeutics presents PTK7 data at WCLC 2026 - TheFly
- 5 weeks ago - Whitehawk Therapeutics Presents Real-World Analyses Supporting PTK7 as a Durable ADC Target in EGFR Wild-Type Non-Small Cell Lung Cancer at WCLC 2026 - PRNewsWire
- 5 weeks ago - Whitehawk Therapeutics Appoints Vijay Iyengar, MD, to Board of Directors - PRNewsWire
- 7 weeks ago - Whitehawk Therapeutics to Participate in Upcoming Investor Conferences - PRNewsWire